It’s only fair to share… Napazimone CAS 1800405-30-4 MF C14H12N2O2 MW240.26 g/mol 2-(propan-2-yl)-1H-naphtho[1,2-d]imidazole-4,5-dioneNAD(P)H dehydrogenase [quinone] 1 (NQO1) activator, KL 1333, KL-1333, NA2ZOL5UGM Napazimone (also known as KL1333) is an investigational small molecule drug currently being developed for the treatment of primary mitochondrial disease. It is an orally available modulator that aims to improve energy production in patients with rare genetic …